As the prevalence of obesity and DM continue to rise [27,28], along with increasing rates of elective spine surgery [29,30] and GLP-1 RA prescriptions [31], spinal surgeons are likely to encounter these medications more frequently. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.